Suppr超能文献

促红细胞生成素及其氨甲酰化衍生物对实验性顺铂外周神经毒性的保护作用。

Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity.

作者信息

Bianchi Roberto, Brines Michael, Lauria Giuseppe, Savino Costanza, Gilardini Alessandra, Nicolini Gabriella, Rodriguez-Menendez Virginia, Oggioni Norberto, Canta Annalisa, Penza Paola, Lombardi Raffaella, Minoia Claudio, Ronchi Anna, Cerami Anthony, Ghezzi Pietro, Cavaletti Guido

机构信息

Mario Negri Institute for Pharmacological Research, Milan, Italy.

出版信息

Clin Cancer Res. 2006 Apr 15;12(8):2607-12. doi: 10.1158/1078-0432.CCR-05-2177.

Abstract

PURPOSE

Antineoplastic drugs, such as cisplatin (CDDP), are severely neurotoxic, causing disabling peripheral neuropathies with clinical signs known as chemotherapy-induced peripheral neurotoxicity. Cotreatment with neuroprotective agents and CDDP has been proposed for preventing or reversing the neuropathy. Erythropoietin given systemically has a wide range of neuroprotective actions in animal models of central and peripheral nervous system damage. However, the erythropoietic action is a potential cause of side effects if erythropoietin is used for neuroprotection. We have successfully identified derivatives of erythropoietin, including carbamylated erythropoietin, which do not raise the hematocrit but retain the neuroprotective action exerted by erythropoietin.

EXPERIMENTAL DESIGN

We have developed previously an experimental chemotherapy-induced peripheral neurotoxicity that closely resembles CDDP neurotoxicity in humans. The present study compared the effects of erythropoietin and carbamylated erythropoietin (50 microg/kg/d thrice weekly) on CDDP (2 mg/kg/d i.p. twice weekly for 4 weeks) neurotoxicity in vivo.

RESULTS

CDDP given to Wistar rats significantly lowered their growth rate (P < 0.05), with slower sensory nerve conduction velocity (P < 0.001) and reduced intraepidermal nerve fibers density (P < 0.001 versus controls). Coadministration of CDDP and erythropoietin or carbamylated erythropoietin partially but significantly prevented the sensory nerve conduction velocity reduction. Both molecules preserved intraepidermal nerve fiber density, thus confirming their neuroprotective effect at the pathologic level. The protective effects were not associated with any difference in platinum concentration in dorsal root ganglia, sciatic nerve, or kidney specimens.

CONCLUSIONS

These results widen the spectrum of possible use of erythropoietin and carbamylated erythropoietin as neuroprotectant drugs, strongly supporting their effectiveness.

摘要

目的

顺铂(CDDP)等抗肿瘤药物具有严重的神经毒性,可导致致残性周围神经病变,出现化疗诱导的周围神经毒性的临床症状。有人提出联合使用神经保护剂与CDDP来预防或逆转这种神经病变。在中枢和外周神经系统损伤的动物模型中,全身给予促红细胞生成素具有广泛的神经保护作用。然而,如果将促红细胞生成素用于神经保护,其促红细胞生成作用可能会导致副作用。我们已成功鉴定出促红细胞生成素的衍生物,包括氨甲酰化促红细胞生成素,它们不会提高血细胞比容,但保留了促红细胞生成素发挥的神经保护作用。

实验设计

我们之前已开发出一种实验性化疗诱导的周围神经毒性,它与人类的CDDP神经毒性非常相似。本研究比较了促红细胞生成素和氨甲酰化促红细胞生成素(50微克/千克/天,每周三次)对CDDP(2毫克/千克/天,腹腔注射,每周两次,共4周)体内神经毒性的影响。

结果

给予Wistar大鼠CDDP显著降低了它们的生长速度(P < 0.05),感觉神经传导速度减慢(P < 0.001),表皮内神经纤维密度降低(与对照组相比,P < 0.001)。联合给予CDDP和促红细胞生成素或氨甲酰化促红细胞生成素可部分但显著地防止感觉神经传导速度降低。两种分子均保留了表皮内神经纤维密度,从而在病理水平上证实了它们的神经保护作用。这些保护作用与背根神经节、坐骨神经或肾脏标本中铂浓度的任何差异均无关。

结论

这些结果拓宽了促红细胞生成素和氨甲酰化促红细胞生成素作为神经保护药物可能的应用范围,有力地支持了它们的有效性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验